Researchers in Qatar are making use of precision medicine to fight against breast cancer as several steps are being adopted to prevent and treat the disease.
Precision medicine is providing new hope to patients and their families in Qatar, utilising international and local medicine-based evidence with Qatar’s unique
The Bone Marrow Transplant Unit at the National Centre for Cancer Care and Research (NCCCR), a member of Hamad Medical Corporation (HMC), has successfully
/PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,.